Tessera Therapeutics CEO and Flagship CEO-Partner Mike Severino shares updates on the company’s progress toward developing a potentially curative therapy for sickle cell disease and a new partnership with the Gates Foundation. More from Flagship @ JPM2025 here.
Related Companies
- Tessera Therapeutics Founded: 2018
